Nolato AB (publ) (NOLA_B) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to today's presentation with Nolato, who is going to present the report for the fourth quarter of 2025. With us here to present today is CEO Christoph Wahlquist and CFO Per-Ola Holmström. After the presentation, there will be a Q&A, so if you're calling in and want to ask a question, please press star 9 to raise your hand and then star 6 to unmute yourself when handed the word. You can also send in questions via the form to the right. And with that said, I hand over the word to you guys. Thank you, and welcome to the presentation of Nonato's fourth quarter of 2025. Starting on page two, we had a sales that totaled just shy of 2.3 billions in the quarter, which gives a growth of approximately 2% adjusted for currency. We saw an increased growth rate for the medical solutions business area at 5%. We saw a decrease of approximately 1% for engineered solution adjusted for currency. We had some headwinds on the sales in the last part of the quarter due to Christmas holidays and during that time. Our operating profit ended up at $236 million in comparison to $240. This was strongly affected by currency headwinds of 6%. The margin rose to 10.4, so we saw improved margins in both areas, but sequentially lower due to somewhat weaker volumes during the Christmas break, and also some startup costs for the new programs in the United States. If we focus on the full year of 2025, we ended up at close to $9.5 billion in sales. That was correspondent to a 2% increase adjusted for currency. We saw an operating profit increase 11%, even though we had a strong currency headwind. The margin improved and ended up at 11.3%. in comparison to 9.9. So we saw a full 1.4 percentage points increase of margin. The earnings per share ended up at 2.88 SEC per share. And we have a...